XERS

XERIS BIOPHARMA HOLDINGS INC

Healthcare | Small Cap

$0.00

EPS Forecast

$80.88

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31 soon

Proximilar's AI forecasts

EPS Forecast:

$0.00

Revenue Forecast:

$80.88

EPS Surprise Forecast:

$0.002

Revenue Surprise Forecast:

$1

Post-release price volatility - Very high

Post-release Overnight Move:

±11.1%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

56%

Probability of beating revenue consensus:

64%

Probability of beating both EPS & revs consensus:

42%

Probability of missing both EPS & revs consensus:

23%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-2

Beta (β)

Forward Looking Beta (β):

0.86

Earnings volatility

EPS standard deviation:

$0.05

Revenue standard deviation:

$7

As % of share price:

0.88% MEDIUM

As % of market cap:

0.68% LOW

Confidence intervals and percentiles

EPS 95th %ile:

$0.06

Revenue 95th %ile:

$89

EPS 75th %ile:

$0.02

Revenue 75th %ile:

$83

EPS 25th %ile:

-$0.01

Revenue 25th %ile:

$79

EPS 5th %ile:

-$0.06

Revenue 5th %ile:

$74

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

42% HIGH

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

54% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$27

Bid-ask per Share:

$0.015